FEATURED

Advertisement
Sign Up for Newsletter

NEWS

Genomic Tests Guide Chemotherapy Decisions in Advanced Prostate and Breast Cancer: Landmark Evidence from...

Peter Hofland -

Researchers Map Key Protein Linked to Cancer and Neurological Diseases: Structural Insights into PKCβ...

Editorial Team -

CT-P72/ABP-102: A Next-Generation HER2×CD3 T-Cell Engager for Solid Tumors – Preclinical Efficacy and Therapeutic...

Editorial Team -

Practice-Changing Advances in Early HER2-Positive Breast Cancer: ASCO 2026 and FDA Approvals Establish Trastuzumab...

Peter Hofland -

ICAM1-high Neutrophils Promote Metastasis in Triple-Negative Breast Cancer Through Symbiotic Adhesion and Reverse Migration

Editorial Team -

Colorectal Cancer Is Rising in Younger Adults. Treatment Must Catch Up.

Maggie Eidson Fader, MD -

More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.

Natalie Krebs -

First Patient Enrolled in Oncopeptides’ Window-of-Opportunity Study Evaluating Peptide Drug Conjugate in Glioblastoma

Editorial Team -

Nearly Half of Frontline NHS Staff Encounter Nutrition Misinformation Weekly as Online Cancer Myths...

Editorial Team -

A Machine Learning Model to Distinguish Clonal Hematopoiesis–Derived Variants in Liquid Biopsies from Patients...

Peter Hofland -

Phase 1b/2a Study Shows Positive Results for Fostrox Plus Lenvatinib in Advanced Hepatocellular Carcinoma

Peter Hofland -

Crafting a Caffeine-Activated Safety Switch for Controlling Engineered Cell Therapies

Peter Hofland -

CONFERENCE COVERAGE

Genomic Tests Guide Chemotherapy Decisions in Advanced Prostate and Breast Cancer: Landmark Evidence from...

Peter Hofland -

Practice-Changing Advances in Early HER2-Positive Breast Cancer: ASCO 2026 and FDA Approvals Establish Trastuzumab...

Peter Hofland -

Asciminib Maintains Superior Efficacy and Favorable Safety Profile in Newly Diagnosed Chronic Myeloid Leukemia

Peter Hofland -

From Data to Delivery: How Real-World Evidence Is Transforming Oncology Care

Jessica K. Paulus, ScD -

ASCO 2026: Phase 1 Study of Denileukin Diftitox Plus Pembrolizumab in Recurrent or Refractory...

Peter Hofland -

TLX591-Tx in Combination With Standard-of-Care in Metastatic Castration-Resistant Prostate Cancer: Results From Part 1...

Peter Hofland -

Advances in Molecular Residual Disease Detection and Risk Stratification: Insights from Abbott Cancer Diagnostics

Peter Hofland -

Tarlatamab Demonstrates Superior Intracranial and Systemic Efficacy in Relapsed Extensive-Stage Small Cell Lung Cancer:...

Peter Hofland -

Darovasertib Plus Crizotinib Demonstrates Significant Clinical Benefit in First-Line HLA-A*02:01-Negative Metastatic Uveal Melanoma: Primary...

Peter Hofland -

Updated Phase 1 Data for IMA401 MAGEA4/8 TCR Bispecific: Clinical Activity and Tolerability in...

Peter Hofland -

What to Expect at ASCO 2026 —Translating Science to Practice

Peter Hofland -

Conference Coverage at ASCO 2026: Our Team’s Expert Insights from Onco’Zine, ADC Review, and...

Peter Hofland -
Advertisement
Sign Up for Newsletter

EDITORIAL

ERIC ROSENTHAL REPORTS

EXPERT INTERVIEWS

spot_img
spot_img
spot_img
spot_img
spot_img
spot_img